ALVAC gp100 vaccine
Term · Oncology and biomedicine · MLC-T-ONC-010002
A vaccine composed of the replication-defective plaque purified recombinant canarypox virus (ALVAC) that encodes the glycoprotein 100 (gp100) gene, with potential antineoplastic activity. Vaccination with ALVAC gp100 may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for the gp100 melanoma antigen, resulting in decreased tumor growth.
| Identifier | MLC-T-ONC-010002 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ALVAC gp-100 vaccine; gp100 ALVAC vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010002",
"term": "ALVAC gp100 vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine composed of the replication-defective plaque purified recombinant canarypox virus (ALVAC) that encodes the glycoprotein 100 (gp100) gene, with potential antineoplastic activity. Vaccination with ALVAC gp100 may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for the gp100 melanoma antigen, resulting in decreased tumor growth.",
"synonyms": [
"ALVAC gp-100 vaccine",
"gp100 ALVAC vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alvac-gp100-vaccine/"
}
Record 917 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.